Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA) : a cross-sectional study in Ecuador. / Tamarozzi, Francesca; Guevara, Ángel G.; Anselmi, Mariella; Vicuña, Yosselin; Prandi, Rosanna; Marquez, Monica; Vivero, Sandra; Robinzón Huerlo, Francisco; Racines, Marcia; Mazzi, Cristina; Denwood, Matthew; Buonfrate, Dora.

I: The Lancet Global Health, Bind 11, Nr. 5, 2023, s. e740-e748.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Tamarozzi, F, Guevara, ÁG, Anselmi, M, Vicuña, Y, Prandi, R, Marquez, M, Vivero, S, Robinzón Huerlo, F, Racines, M, Mazzi, C, Denwood, M & Buonfrate, D 2023, 'Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador', The Lancet Global Health, bind 11, nr. 5, s. e740-e748. https://doi.org/10.1016/S2214-109X(23)00108-0

APA

Tamarozzi, F., Guevara, Á. G., Anselmi, M., Vicuña, Y., Prandi, R., Marquez, M., Vivero, S., Robinzón Huerlo, F., Racines, M., Mazzi, C., Denwood, M., & Buonfrate, D. (2023). Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador. The Lancet Global Health, 11(5), e740-e748. https://doi.org/10.1016/S2214-109X(23)00108-0

Vancouver

Tamarozzi F, Guevara ÁG, Anselmi M, Vicuña Y, Prandi R, Marquez M o.a. Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador. The Lancet Global Health. 2023;11(5):e740-e748. https://doi.org/10.1016/S2214-109X(23)00108-0

Author

Tamarozzi, Francesca ; Guevara, Ángel G. ; Anselmi, Mariella ; Vicuña, Yosselin ; Prandi, Rosanna ; Marquez, Monica ; Vivero, Sandra ; Robinzón Huerlo, Francisco ; Racines, Marcia ; Mazzi, Cristina ; Denwood, Matthew ; Buonfrate, Dora. / Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA) : a cross-sectional study in Ecuador. I: The Lancet Global Health. 2023 ; Bind 11, Nr. 5. s. e740-e748.

Bibtex

@article{3bab1ddbd3e3403cbefdd3cfa77da036,
title = "Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): a cross-sectional study in Ecuador",
abstract = "Background: WHO recommends the implementation of control programmes for strongyloidiasis, a neglected tropical disease caused by Strongyloides stercoralis. Specific recommendations on the diagnostic test or tests to be used for such programmes have yet to be defined. The primary objective of this study was to estimate the accuracy of five tests for strongyloidiasis. Secondary objectives were to evaluate acceptability and feasibility of use in an endemic area. Methods: The ESTRELLA study was a cross-sectional study for which we enrolled school-age children living in remote villages of Ecuador. Recruitment took place in two periods (Sept 9–19, 2021, and April 18–June 11, 2022). Children supplied one fresh stool sample and underwent blood collection via finger prick. Faecal tests were a modified Baermann method and an in-house real-time PCR test. Antibody assays were a recombinant antigen rapid diagnostic test; a crude antigen-based ELISA (Bordier ELISA); and an ELISA based on two recombinant antigens (Strongy Detect ELISA). A Bayesian latent class model was used to analyse the data. Findings: 778 children were enrolled in the study and provided the required samples. Strongy Detect ELISA had the highest sensitivity at 83·5% (95% credible interval 73·8–91·8), while Bordier ELISA had the highest specificity (100%, 99·8–100). Bordier ELISA plus either PCR or Baermann had the best performance in terms of positive and negative predictive values. The procedures were well accepted by the target population. However, study staff found the Baermann method cumbersome and time-consuming and were concerned about the amount of plastic waste produced. Interpretation: The combination of Bordier ELISA with either faecal test performed best in this study. Practical aspects (including costs, logistics, and local expertise) should, however, also be taken into consideration when selecting tests in different contexts. Acceptability might differ in other settings. Funding: Italian Ministry of Health. Translation: For the Spanish translation of the abstract see Supplementary Materials section.",
author = "Francesca Tamarozzi and Guevara, {{\'A}ngel G.} and Mariella Anselmi and Yosselin Vicu{\~n}a and Rosanna Prandi and Monica Marquez and Sandra Vivero and {Robinz{\'o}n Huerlo}, Francisco and Marcia Racines and Cristina Mazzi and Matthew Denwood and Dora Buonfrate",
note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license",
year = "2023",
doi = "10.1016/S2214-109X(23)00108-0",
language = "English",
volume = "11",
pages = "e740--e748",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "The Lancet Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA)

T2 - a cross-sectional study in Ecuador

AU - Tamarozzi, Francesca

AU - Guevara, Ángel G.

AU - Anselmi, Mariella

AU - Vicuña, Yosselin

AU - Prandi, Rosanna

AU - Marquez, Monica

AU - Vivero, Sandra

AU - Robinzón Huerlo, Francisco

AU - Racines, Marcia

AU - Mazzi, Cristina

AU - Denwood, Matthew

AU - Buonfrate, Dora

N1 - Publisher Copyright: © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

PY - 2023

Y1 - 2023

N2 - Background: WHO recommends the implementation of control programmes for strongyloidiasis, a neglected tropical disease caused by Strongyloides stercoralis. Specific recommendations on the diagnostic test or tests to be used for such programmes have yet to be defined. The primary objective of this study was to estimate the accuracy of five tests for strongyloidiasis. Secondary objectives were to evaluate acceptability and feasibility of use in an endemic area. Methods: The ESTRELLA study was a cross-sectional study for which we enrolled school-age children living in remote villages of Ecuador. Recruitment took place in two periods (Sept 9–19, 2021, and April 18–June 11, 2022). Children supplied one fresh stool sample and underwent blood collection via finger prick. Faecal tests were a modified Baermann method and an in-house real-time PCR test. Antibody assays were a recombinant antigen rapid diagnostic test; a crude antigen-based ELISA (Bordier ELISA); and an ELISA based on two recombinant antigens (Strongy Detect ELISA). A Bayesian latent class model was used to analyse the data. Findings: 778 children were enrolled in the study and provided the required samples. Strongy Detect ELISA had the highest sensitivity at 83·5% (95% credible interval 73·8–91·8), while Bordier ELISA had the highest specificity (100%, 99·8–100). Bordier ELISA plus either PCR or Baermann had the best performance in terms of positive and negative predictive values. The procedures were well accepted by the target population. However, study staff found the Baermann method cumbersome and time-consuming and were concerned about the amount of plastic waste produced. Interpretation: The combination of Bordier ELISA with either faecal test performed best in this study. Practical aspects (including costs, logistics, and local expertise) should, however, also be taken into consideration when selecting tests in different contexts. Acceptability might differ in other settings. Funding: Italian Ministry of Health. Translation: For the Spanish translation of the abstract see Supplementary Materials section.

AB - Background: WHO recommends the implementation of control programmes for strongyloidiasis, a neglected tropical disease caused by Strongyloides stercoralis. Specific recommendations on the diagnostic test or tests to be used for such programmes have yet to be defined. The primary objective of this study was to estimate the accuracy of five tests for strongyloidiasis. Secondary objectives were to evaluate acceptability and feasibility of use in an endemic area. Methods: The ESTRELLA study was a cross-sectional study for which we enrolled school-age children living in remote villages of Ecuador. Recruitment took place in two periods (Sept 9–19, 2021, and April 18–June 11, 2022). Children supplied one fresh stool sample and underwent blood collection via finger prick. Faecal tests were a modified Baermann method and an in-house real-time PCR test. Antibody assays were a recombinant antigen rapid diagnostic test; a crude antigen-based ELISA (Bordier ELISA); and an ELISA based on two recombinant antigens (Strongy Detect ELISA). A Bayesian latent class model was used to analyse the data. Findings: 778 children were enrolled in the study and provided the required samples. Strongy Detect ELISA had the highest sensitivity at 83·5% (95% credible interval 73·8–91·8), while Bordier ELISA had the highest specificity (100%, 99·8–100). Bordier ELISA plus either PCR or Baermann had the best performance in terms of positive and negative predictive values. The procedures were well accepted by the target population. However, study staff found the Baermann method cumbersome and time-consuming and were concerned about the amount of plastic waste produced. Interpretation: The combination of Bordier ELISA with either faecal test performed best in this study. Practical aspects (including costs, logistics, and local expertise) should, however, also be taken into consideration when selecting tests in different contexts. Acceptability might differ in other settings. Funding: Italian Ministry of Health. Translation: For the Spanish translation of the abstract see Supplementary Materials section.

U2 - 10.1016/S2214-109X(23)00108-0

DO - 10.1016/S2214-109X(23)00108-0

M3 - Journal article

C2 - 36972722

AN - SCOPUS:85151472281

VL - 11

SP - e740-e748

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 5

ER -

ID: 343338815